C R r s d iag no sis, ep ide m io logy, recov ery, heal th eco no m ics and rare p re5<' ntations C RPS is a pa infu l con d itio n which usually dev elops after trauma to a limb . It is chnracrerbed by li m b_confl n~-d sensory, autonomic, mo to r, skin and bon e cha nges, btu the lead sympto m is pain. Earlier names for th e condi tion are given in app endix A. 111e C Rrs dia gno stic crite ria have recently been up dated ('B ud ape sr Criteria",
appen di x B}, becau se ea rlier criteria were nor specific . These new criteria, although widely used have nOI yet been formally ado pted by rhe Int ern ational Associati o n for the Stud y of Pain ( I) . O ver the past 10 years many investigators , scient ists an d clini cians alike have jointl y ach ieved remarkable progr ess in understanding and treating C RPS. These efforts have been e nhanced by th e success of the 'TREN D" conso rt ium led by Prof. J.J. va n Hilren from Leiden and Prof. van der H elm from Delft , who secured in th e early 20 00's over 20 m illio n Eurc in research su ppo rr from th e Durch M inisrry of Econ omic Affairs to study CRPS and related co nd itio ns.
As a result of th e first ever. population based Europ ean epidem iolog ical study, we no w unde rstand thai C RPS is mo re commo n (incide nce: 26fJOO.OOO po pulation) than previou sly thought (for com parison, th e incide nce of Mul tiple Sclerosis in th e UK is estima ted at 4 /100.000). It has its pea k in people aged 55-75 years, bur may take a mor e beni gn co urse in this gro up, than in younge r partcnrs (2), C k l'S is associated with m igra ines, osteoporosis and asthma (3). Overall 85% of patie nts will have substan tial pain redu ction within th e flrst 1-2 years afie r d isease o nset. How ever only 30% of partenrs co nsider rhernselves fully recovered even 6 years after d isease o nset, and o nly 40% of people who wor ked before will return 10 their prio r work. C RI'S which has no t im proved ear ly is less likely 10 improve later (4) .
A defin it ion of recovery fro m C RPS has not yet bee n achieved.
Auto no mic signs usually reduce with rime, even where pain persists (5) . Wirhou l autonomi c signs, a dia gnosis of C Rrs can o ften no t be mad e (Append ix B), so that patients may 'lese' their init ial di agnosis ali: er some years, but cont inue to suffer from pain", It is likely thar we will in th e future define a 'p<>st. C RPS synd rome' for patients who have fulfilled th e Buda pest c rite ria in th e past. Sim ilar as posrherperic I An r"dirr 1,",10'1 u' <Ir mmed 'Omr"'-H"rdrn rrllrrid: but WI" S,rpl/{/tl Onlrh{ tIIldNomu/II Hardor",M, Ih'/l Imtrad rhr 1/"'''' 'Blldtlprll mlrna"is usrd 10 rtf /rrt Ihr /or"IIOII ofl"r rOJMI/! IIl «mft rtJJrr. "'CRPS NOS ' (1101 olhrr",I'r ,prdjird) I, ,hr now rtrom", ,,,drd '''1/1fir dUM enm which ;'"d" fufJicirnt Ilumb" of,lg", ("pp",dlx A) In t!lrpmt. but kuk sig'" 011 rXilt'lln"tlon. neur algia. bur unlik e lower back pain and fibromyalgia alrnosr all C RPS is mon op hasic (o nce n uly disap peared it won't co me back), wir h o nly 2% relapsing-remitting cases (6), Becau se mo st cases ofCRPS get better early o n, for clinical trial pur po ses it can ma ke sense to sepa rately co nside r the difhculr-rotreat lon gsrand mg C R rs (wit h > 6 mom hs d isease duratio n). Th is co ncep t has received mo re att ention ove r th e last J() years. Almost all clinical stud ies in lon gstandin g C RPS have bee n co nd ucted after 2000. For health econo mic calculations, the Naricnallnstinue for C linical Excellence (N IC E) ha s assumed a 15 year estimated average C RI'S durat ion fo r those cases oflo ngstanding C R I'S which req uire spinal cord srim ula rio n (h n p:l/ www.nice.org.uk /ni cemcdiaJ Iive/1108 2f42367 / 42367.pdf, page 2 1).
Sim ila r as many o ther chro nic pain s (7), C RI'S is expensive.
Average an nual health -care costs (exclud ing physioth erapy) in th e Nethe rlands were £5700 in 1998. Be c ause paricurs with lon gstanding e RPS alm ost never work (8) overall COStS are higher. Return to wor k rates may remain low even in patient s who successfully rec eived spinal co rd sti m ulatio n (SCS) rrearr ncm (Pro f. Keml er, perso nal co mm unicatio n). Thae is in spi te of th e fact th at SCS treatment Imp roves parkn l5' qual ity ofli fe (9). The average quali ty of Hfe of pa tient s with lon gstanding C RPS is very low, wit h an Euroquol score of 0.2 to I (8), Fo r comparlson rhc average scores in multi ple selerosis are0.4-0.5 -1 ( 10 ),
We all kn ow rhar patlc urs with C R PS can present in ma ny d ifferent ways. For exam ple, limb s can be hOI or co ld, shiny, swollen o r thin. red o r blue, with scaling or with clammy skin . However th ere a re some rare pr esentations/complicati on s. which even pain specialists may only enco unter every few years. These include C RrS with spo nt aneous onset (no trauma), with a painful sho ulder and a uto no m ic signs (but not pain) o nly in th e ipsilateral ha nd (formerly termed 'should er-hand synd rome'), rhe .lr read ing of sym pto ms 10 a nothe r lim b, ch ronic lym phede ma, skin ulcerations (often with secondary infections, Figure I ), blister formatio n, d ystoni a, severe at rophy and myocl onus; the co mplica tio ns a re more com mon in you ng wo men ( I I) .
Ca uses a nd trearm enrs of eRrs
There are currently seven m ajo r wn(;ept s a bout th e CRPS etiology.
These co ncepts e m also explain the rario nale for mosr clin ical rrearmems ll1 : deemp hasize th e impo rt ance of sympathetic dysregulanon for C RPS pain.
2) Cmmll trmititation 'II th, drivi1/g fim orfor CRPS Ce nt ral sensmserton is the molecular process rhar corresponds to the clinical o bservatio n that after a per iod of int ense o r repea ted noxious snmula no n, in nocuo us (no n-noxiou s) stimul i become painful and remain painfu l (fo r a wh ile ar least) even if rhe initial noxious st imulation has subsided . Th is mechan ism is import a nt in most ch ro nic pains ( 19) , Becau se Ncmcrhyl Dcaspanare (N M D A) recept ors play a crtrtcal role in central sensutsanon, th e recent obse rvat ion in IWO rando r nired controlled trials that low-dose intravenou s keta min e (a n NM D A-anragonlst) can d ramat ically red uce C RPS pain indicates an lmportanr role for such central senstdsa do n (20) . There is currently no RC T evide nce for highdose 'ketarnine-co rna' und er lnt enslve care co nditions, which has so metimes been discussed in rhe media (2 1). In the rwo published lo w-dose RCT's, kcmmlne stro ngly reduced average pain int ensity for several weeks, independent of the C R I'S d isease d uratio n. It is un certa in whethe r th ese research find ings will tra nslate int o clinical pr actic e. Side effects from repeale d keramine infusions are poorly understood, with so me experts expressing co nce rn about potential neurotoxicity (22) . C urren t pro toco ls fo r Keta min e rreatrn enr a re expensive a nd cumbe rsome. In the published protoco ls eithe r a S-day hospital in parlen r stay, o r 10 consecutive wo rking-days o urpanenr tr eatments are required 10 achieve pain relief lasling several week>.
Recently a s mall pilot trial suggested efficacy of int raveno us magnesium which , simila r 10 Kerami nc may work rc reduce centr al scnsirlsarion (23 Rei 'S cond ucted to assess th is rrearm ent have bee n negative{I 2).
G iven the expe rience sha red by mOSI clin icia ns that this met hod actuall y does red uce pain in some patient s, o ne wonde rs whether it is per hap s the appli cation of tou rniquet wh ich conveys that effect. Of not e, o ne stu dy has shown that IVRSB with saline is mo re effective than IV RSB with guanethid ine (16) . local anaesthetic appli catio n to the symparhenc ganglia e m relief pain sho rt ter m in selected pat ient s (17) , but repea t application does no t prolon g that effect (18) .
These trial resu lts have cont ribut ed 10 prompting CRPS expens to 
3) Autoimmul/itymay ram, CRPS
Thi s is a novel concept which has recently bee n sugges ted bot h by o ur and Franz Blacs's gro up . Borh g roups fou nd eviden<:e for ami -n euronal autoantibodies ill C RPS (24) (25) (26) . We have shown in a recent Re r ehar 10 w--<; 10se in traveno us lmmunogloh ulln (IY1G ) is efflX "live in longsrandi ng C RPS (27 ) . Pain relief in respo nders lasted for five week> on avera ge. Mo S! llIedkal condiricns which respo nd to IVI G rrearmen r are autoimmune in nature, a nd associated whh fu nctionally lmpcrtanr autoantibodies. In o ur trial, patients ryplcally respo nded with in 2 days, which is at}'Pk al, If auro anribodics arc ind eed respo nsible, rhen th e nK,<:haniSlll of th eir lnrcractlon with the nervo us system sho uld be d ifferent fro m that des c ribed in o the r condino ns.
4) CRPS (/J a m ull of limb isrhemia oriJrh,mia-rt' prrjilSio1/ i I/jilT)
A recent pilot -tr ial showed that Tadalaf i l a phosphodiesterase in hibito r, red uces pain in some patients with C RpS who have w id lim bs (28 ) . Tedalaf i l is a vasod ilator and it may be that th e vasodila rory property of this d rug is responsible fo r pain relief, 
radiu s fract ure has be en explained by th e prod union of free rad icals after such injury (30) .
5) Cortical r(orgfllliSrltioll is m pomib/(for thl' CRPSp{/ill
Th is is anoth er excmng clinical and research development.
Fun ctional MRI stud ies over th e last 10 years have d early shown rhar the senso r}' representa tio n of th e C RPS affected limb is altered (shrun k and shi fted), thar rhe degree of th e alteratio n correspo nd, 10 the pain inten sity, and th at pain reduction is associated with normalis.ltion (31 ;321, There are also Important changes in rhc mo to r CO rtex. Wc do n't know whe ther th ese changes are secondary, or whe the r th t')' relate to th e C RrS pat hophysiology. C lin ically we have learned That patients often feel alicnarlon with th eir affecwd limb, which can feel strange and disfigured and OUl of place (33); these feelings are often no t com mun ic:ned 10 avoid the SUSpl,<IOO danger of no t bein g believed. Some patient s can't Stop thi nk ing about amputati ng th at limb . These feelings may be associated w ith the altered co rt ical limb representation. alth ough this has yet 10 be confi rmed . Co mputer-based 'g raded motor imagery' (G MI), which involves an exercise to tra in the brain in berrer recogn izing the affected limb can red uce (34) pain and swelling (35) . Mirror
IherapyN was first applied 10 th e rrearmene of C RPS by Candy
McCa be's group (36) . h has been show n 10 reduc e pain in C RPS (borh early and late)after stroke (37) . 
7) !lIjI'lmmaliOlI (till txplttill cliniml CRPS ,igm
Th is was o riginally propo sed by Peter Sudec k ('Sudl:Ck's atrophy' ) (45) . Th e painful C RPS·a ffl'Cled limb is often red , hor and swollen, with reduced fun ction : the five card inal signs of inflammation (46) .
And indeed recent research fou nd th at inRam marory mar ke rs are elevated in blister Huid from C RPS-alfecred limbs (47 ) . H owever rhe titre of th ese markers is no r related 10 rhe pain int ensity a nd mark ers can rema in high even if th e pain d isappear s (48 ) . One small rand o m ized control trial has suggesred that ste roid treat ment is effective in very early CRrs a nd some clinicians find this o bservano n co nfirmed by th eir clinical experience (49) . In longsta nd ing CRI'S intrathecal steroi ds are nat effective (50) . TNf-alpha rrenmenr has been prop osed , bur no RC T has bee n cond ucted. l .enalid o mid e, a highl y toxic anti-inflammato ry thalidom ide derivative W<lS rested in o ne of the largest ever tr ials in C R PS, bur untonunarely the co mpanr (Celge ne) has nOI published rhe results.
It remains unclear which cells lnltiate C R PS inflammation . One possibility is that neuropepndes. antidromically released from sensory neuro ns ca use skin reddenin g and swelling thu s producmg C RPS signs ('neuroge nic inflammation'); imm une mediato r release may follow. In detailed expe riments, Frank Birklein's team has indeed confi rmed an abno rmality uf the neurop epnde handl ing in C RPS and termed what they fou nd 'facllirated neurogenic inflam rnarion'(S I). They showed that when c-fibres in affecred {and ro a lesser degree also unaffec ted (52» limbs are stim ulated , CRPS patients respon d with r nuch Stronger [neuropep ride-rned iared) skin redd en ing and swelling than co ntrol pat ient s. The cause is unclear.
It is possible tha t in C RrS these ncurop epddes. OIKe released are not p roperly merabolbed. The Import an ce of neuropep rides for the C Rrs patho physiology hal gained furt her credence by the recenr finding that C RPS is associated with intak e of angjcrensicn conve rting enzyme (ACE)-inhibiror medicatio n (53) . ACE rnerabolises the neuropeprid es substance P and brad ykinin to inact ive fo rms, th us ACE-inh ibitol> may lead to higher t issue levels of both neuropcpndes. Up until no w, these interestin g find ings have not rranslared into clin ical treatments.
Alternative concep ts on the CRrs parhophysiclogy Some auth ors have placed C Rrs broadly into the co ntext of somatofo rm disord ers or malin gering. A few aut hors have also taken the fact that CRI'S I~'I is not associated with structuralles ions as evide nce that thi s prohlem sho uld he, at k>;)st in pa rt of psychological origin (54) . Recent more systematic investigations were not corrobo rative (35 5). StrI.'SSful life events may hemor e common in patients before developrn em of the cond itio n (55) . Some people selfindu ce injuries 10 resem ble C RPS (56) .
Although th is has not been systematically assessed, it is my clinical impre ssion that patients can feel srtgmarised by health professionals who did nor believ e thnt their condition is ' real'. The sclcnrtfic evidence in suppo n of somansauo n and ma lingering as causes for C RPS is meagre at best. Int erestin gly, almost hidd en from mose d inidans there call he intense arguments in the medico-legal co ntexts about the causes of C RPS. Stakes in the co ntext of workrelated injuries can be high, and 'psychogenic' concepts about the C RPS pathophysiology may be cited more frequently tha n would be in clinical situations.
In co mmon with other chro nic pain s, CRPS sho uld best be seen as a bio psychosocial co nditio n. Randomised controlled trials ofcognitive behavioural ther apy in CRPS arc st ill missing. The UK guideline group will recom mend cognitive behavioura l therapy as one of the four pillars of treatment ( Figure 2 ).
Genenc pred isposition is impo rtant in a wide range of medical disorders. Several groups have examined genetic associations in C RPS, but to dat e no ro bust associati on has been fou nd (57) .
Ge no me-w ide association studies have nOI yet been accomplished .
VI CRPS 1/2 iJ d(finrd <IS withlu'ifhol<1d.mJltg( to a maior ,,(rV(, Recommend ations fo r t he tre atme n t of e Rr s (il patients sho uld be educat ed about CRPS and be given simple information on self-manageme nt such as advice to dtrec r att enti on 10 the limb and to stro ke and use il frequently and gemly.
[ii) most pat ient s requ ire specialised ph ysiotherapy delivered by physiothe rapists or occupatio nal therapists experienced in the treatm ent of patients with chro nic pain (Figure 2) . Th is sho uld be initiated as early as possible, recogntztng that advice to gently move the freque ndy red. swollen and painful limb of early CRPS can sometimes appear co unte rin tuitive to patients and pracnnoners. lrnpo rranr met hods include desensirisario n (ru bb ing the affected limb gently with cloth), gradual weight bearing, stretchin g and functional and fine mutor exercises. Since the required expertise to deliver these rrearmems is not universally available, the dev elopm ent of a net work app roach app eal> useful. where stakeholders in a region kno w 10 locate th e regional expert cenrrets) and/or experienced practitionerfs). M ore research is needed to bett er understand the relatio n between early physioth erapy treat ment and prevention of late com plications (such as ankylosis and co ntractu re).
(iii) mult idisciplinary pain management treatment, guided by princip les of cognitive beha vioural therapy sho uld be co nside red early for those patie nts who do not imp rove, and who show signs of distress. Here again stakeholders sho uld know of the nearest cent re which offers such service.
[lv ) a number of novel drug or lnrcr vcmional trcarmenr s, which may provide pai n relief have been described. however confirm atory tr ials are required for mOSI before recomme ndat ions can be given. It is reasonable 10 Initially treat patients wirh dru gs developed for neuropathic pain, although there is no C RPS-specific evidence for any of thes e trcatnt ents Vl1 • In addition , a one off pa midro nate 60mg lv infusion treatm ent sho uld be conside red for those with less tha n 6 mon ths dura tion. Intravenous regional sym pathetic blocks (IVRSB) sho uld no t rou tinely be used in the treannenr of C RI'S since four randor nised cont rolled trials have not demonst rated an y benefit. Pragmati cally, in rhose rare patient s with early CRPS , for whom 101. "<11annesrhedc tnjccnon 10 sympat hetic ganglia provides days or weeks uf pain relief, th is treatment may bridge the lime untilthe disorder gets better by itself, however more research is needed before a recommendation can be made -imp ortantly repeat blocks will nOI prolon g the analgesic effecl. In the UK, spinal cord stim ulato r (SCS) treatment is the only NI C E approved method 10 treat CRrS . Wit h time, the SCS effect docs slowly d iminish, so rhar in the Re T the SCS results d id not exceed tho se in the 'physical the rapy' control group from 3 years after im plantat ion (58) . The authors of the seminal RCT conclude that, altho ugh pat ient satisfactio n was gene rally high, 'the unknown working mechanisms of the (SCS) treatm ent app arentl y do not functio n indefinitel y' (59) . Spinal cord stim ulato r treat ment may be appropriate whe re th ese other treatm ent s do not provide ben efit. Unfortunately, even with best current treatment app roaches some patient s may not experience sufficient pain relief.
(v) p"iOpmlfi~Cllrt' ,md prt'Vl'lIIioli'1Ji" trauma: Th e risk of surge ry causing a severe new C RPS episode in someo ne who had CRPS in rhe pasr is probably neither high nor zero (60) . lr seems commo n sense ro defer op erating in an early case of C RPS umil acut e sympto ms have subsided . if at all possible, to red uce rhe risk of aggravatin g rhe cond ition , though even for such recomme ndation no RCf-derived evide nce exists. 'Ih ere is no evidence for the supe rloriry of any anaesthetic techniq ue ro prevent re-igniting or aggravating CR I'S. 'Ihcrc is preliminary evide nce in favour of giving oral vitamin C after dorsal radius fractur e (500 mg x 50 days), but more evidence is needed before this can he recommended (30) (vi) 101l[-trrl/l carer No r a single publication ro dat e has described how we sho uld care for rhose who have rrialled available ph ysical, behavioural and pain relief treatme nts, but who still have ongoin g pain and a reduced quali ty oflife. Any lon g-term approach shou ld he patien t-centred and includ e facihrared wars for rhe patient 10 wques r re p-up suppor t (e.g. by wa y ofoccasional on -d emand cons ulration with a named specialise physioth erapist. psychologist or doctor}, att endan ce of self-sup po rt grou ps under the umb rella of, or wit h some link to the medical trearmenr centre, and access to informari on about available suppo rt for dcvcloptn g adapted work, leisure and social activities. In a recent series ofC RPS focus group discussions ar our centre , paucms named rhc educat ion of healrhca re professionals, particularly the ir G P's, about C RPS a 101' priority (in prepara tion ). dose to the number of patie nt you see~At least in some UK regions it is not. 'Where are these pariems ? We susf'C'-"l: tha t they may either remain undi agnosed , or that they do not reach pain services.
In order to address these issues, Chris Barker (Specialist in pain Barker has also led efforrs to revise {he G i' ' read codes ' fur C RPS. Read cod es appear when a GI' enters a certain med ical term into the electronic records database. Up un til lase year the term 'CRPS' 0 1 'Complex Regional Pain Synd rome' was not rec ognized , but rhis has now been changed and Gl"s are given the oprion to link to a shn rr expla natory lcatier abou r the condition.
Candy McCa be has previously reported in ' BPS's newsletter un rhe foundation of the 'C RPS Ne twork UK' , a mul tid isciplinary group of currently 10 clinicians and researchers with a special interest in e RpS (6 1). This group aims to enha nce clin ical care for and research into C RPS in the UK, and liaise with othe r Europ ean investigators.
We welcome interested clinicians to join the netwo rk. Sho uld YO Il be interested (membership is Informal and open ), please do comacr our administ rator, Mrs . Yvette Hibb ert fur further infor mation and upcoming mecnn g dates (appe ndix C). As a first joint project we have (in 2008 ) esta blished the UK C RPS registry, sup po rted by the cancer services information techn ology unir at the University Southa mpton. Parricip aring investigators ente r, after taking informed conse nt con racr data fur C RPS pane ms un this web-based dat abase.
By giving co nsent , patien ts agree tha t they can later be contacted by researchers for et hics-approved project s. Database access will be managed by a stee ring co mmittee, which w ill be happy to receive propos-lis fur access from late 20 11. 111e manage mem lead for the registry is Dr. Nic k Shenker (appendix C ). Th e registry currently hold s 140 entr ies of patients w ith lo ngstanding C RPS, and rec ruitme nt is going stro ng.
Fut ure developments: One never knows whnt is aroun d the next co rn er, however for my special area of aut oimmunity and imm un e mod ulation , I suspet;t th at clini cians will event ually be offered a seru m test for C R PS diagnosis, and that novel applicat ions of imm unoglobuli n (such as lo w-dose ho me applicat io n) will he assessed?'!',
SI//1//1/I/, Y
We have learned a lo t abo ut C RPS in the Pa5t 10 years, and we have even been given a glim pse upo n some treatments which, for the first tim e promise effective pain reductio n fur those w ith lon gstandi ng di sease. To dal e all evidence is preliminar y, wit h th e except ion of th at for Spinal Cord Stimulato r treatm ent and, potent ially, the treat ment with bisp hospho nares ( 12)'x. The q uality of cl inical trials has mu ch im proved and th e qua nt ity of research int o the condition has skyrocketed. Wh ile we still do n't know what causes C RPS, one has the sense that effo rts to tackle thi s fascinating, debilitati ng co nd itio n are exem plary for the progress of th e new field of Pain Med icine ro come int o its own. VH! 171t ui( ofimmunog!cbu/im iu tilt UK is mort tightly rtgukllrd dum in othrr cowll rin . bteauSf tllrrt had bun a lack ofmpply in Ihcpall. b,dk atioltJart r,urgoriad illlo ltrvml CO/"Ul1"lid tltrrtllrfy e RPSil l/Otlisud til 'III i"dlmtion.
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